Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up

Elisa Jacobsen Pulczynski; Mikkel Runason Simonsen; Outi Kuittinen; Unn-Merete Fagerli; Martin Erlanson; Øystein Fluge; Sirpa Leppä; Bjørn Østenstad; Alexander Fosså; Mikael Eriksson; Tarec El-Galaly; Hanne Kuitunen; Karin Papworth; Maria Ljungqvist; Martin B. Pedersen; Marjukka Pollari

doi:10.3324/haematol.2024.285207

Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up

Elisa Jacobsen Pulczynski, Mikkel Runason Simonsen, Outi Kuittinen, Unn-Merete Fagerli, Martin Erlanson, Øystein Fluge, Sirpa Leppä, Bjørn Østenstad, Alexander Fosså, Mikael Eriksson, Tarec El-Galaly, Hanne Kuitunen, Karin Papworth, Maria Ljungqvist, Martin B. Pedersen, Marjukka Pollari^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › Research › peer-review

11 Downloads (Pure)

Abstract

Original language	English
Journal	Haematologica
Volume	109
Issue number	7
Pages (from-to)	2359-2363
Number of pages	5
ISSN	0390-6078
DOIs	https://doi.org/10.3324/haematol.2024.285207
Publication status	Published - Jul 2024

Keywords

Aged
Aged, 80 and over
Antineoplastic Agents, Alkylating/therapeutic use
Cancer Survivors
Central Nervous System Neoplasms/drug therapy
Dacarbazine/therapeutic use
Female
Follow-Up Studies
Humans
Lymphoma/drug therapy
Maintenance Chemotherapy
Male
Middle Aged
Temozolomide/therapeutic use
Treatment Outcome

Access to Document

10.3324/haematol.2024.285207Licence: CC BY-NC 4.0

Pulczynski et al. (2024). Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-upFinal published version, 2.62 MBLicence: CC BY-NC 4.0

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Pulczynski, E. J., Simonsen, M. R., Kuittinen, O., Fagerli, U.-M., Erlanson, M., Fluge, Ø., Leppä, S., Østenstad, B., Fosså, A., Eriksson, M., El-Galaly, T., Kuitunen, H., Papworth, K., Ljungqvist, M., Pedersen, M. B., & Pollari, M. (2024). Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up. Haematologica, 109(7), 2359-2363. https://doi.org/10.3324/haematol.2024.285207

@article{69ba05b86ccf4d92b2d47048ca3941cf,

title = "Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up",

keywords = "Aged, Aged, 80 and over, Antineoplastic Agents, Alkylating/therapeutic use, Cancer Survivors, Central Nervous System Neoplasms/drug therapy, Dacarbazine/therapeutic use, Female, Follow-Up Studies, Humans, Lymphoma/drug therapy, Maintenance Chemotherapy, Male, Middle Aged, Temozolomide/therapeutic use, Treatment Outcome",

author = "Pulczynski, {Elisa Jacobsen} and Simonsen, {Mikkel Runason} and Outi Kuittinen and Unn-Merete Fagerli and Martin Erlanson and {\O}ystein Fluge and Sirpa Lepp{\"a} and Bj{\o}rn {\O}stenstad and Alexander Foss{\aa} and Mikael Eriksson and Tarec El-Galaly and Hanne Kuitunen and Karin Papworth and Maria Ljungqvist and Pedersen, {Martin B.} and Marjukka Pollari",

year = "2024",

month = jul,

doi = "10.3324/haematol.2024.285207",

language = "English",

volume = "109",

pages = "2359--2363",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "7",

}

Pulczynski, EJ, Simonsen, MR, Kuittinen, O, Fagerli, U-M, Erlanson, M, Fluge, Ø, Leppä, S, Østenstad, B, Fosså, A, Eriksson, M, El-Galaly, T, Kuitunen, H, Papworth, K, Ljungqvist, M, Pedersen, MB & Pollari, M 2024, 'Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up', Haematologica, vol. 109, no. 7, pp. 2359-2363. https://doi.org/10.3324/haematol.2024.285207

Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up. / Pulczynski, Elisa Jacobsen; Simonsen, Mikkel Runason; Kuittinen, Outi et al.
In: Haematologica, Vol. 109, No. 7, 07.2024, p. 2359-2363.

Research output: Contribution to journal › Comment/debate › Research › peer-review

TY - JOUR

T1 - Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up

AU - Pulczynski, Elisa Jacobsen

AU - Simonsen, Mikkel Runason

AU - Kuittinen, Outi

AU - Fagerli, Unn-Merete

AU - Erlanson, Martin

AU - Fluge, Øystein

AU - Leppä, Sirpa

AU - Østenstad, Bjørn

AU - Fosså, Alexander

AU - Eriksson, Mikael

AU - El-Galaly, Tarec

AU - Kuitunen, Hanne

AU - Papworth, Karin

AU - Ljungqvist, Maria

AU - Pedersen, Martin B.

AU - Pollari, Marjukka

PY - 2024/7

Y1 - 2024/7

KW - Aged

KW - Aged, 80 and over

KW - Antineoplastic Agents, Alkylating/therapeutic use

KW - Cancer Survivors

KW - Central Nervous System Neoplasms/drug therapy

KW - Dacarbazine/therapeutic use

KW - Female

KW - Follow-Up Studies

KW - Humans

KW - Lymphoma/drug therapy

KW - Maintenance Chemotherapy

KW - Male

KW - Middle Aged

KW - Temozolomide/therapeutic use

KW - Treatment Outcome

UR - http://www.scopus.com/inward/record.url?scp=85197812223&partnerID=8YFLogxK

U2 - 10.3324/haematol.2024.285207

DO - 10.3324/haematol.2024.285207

M3 - Comment/debate

C2 - 38546689

SN - 0390-6078

VL - 109

SP - 2359

EP - 2363

JO - Haematologica

JF - Haematologica

IS - 7

ER -

Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up

Abstract

Keywords

Access to Document

AUB Link

Other files and links

Cite this